154 related articles for article (PubMed ID: 7846920)
1. Expression of basic fibroblast growth factor in hyperplastic parathyroid glands from patients with multiple endocrine neoplasia type I.
Komatsu M; Tsuchiya S; Matsuyama I; Kaneko S; Suzuki Y; Ito N; Hanamura N; Seki T; Kobayashi S; Kuroda T
World J Surg; 1994; 18(6):921-4; discussion 925. PubMed ID: 7846920
[TBL] [Abstract][Full Text] [Related]
2. Nuclear DNA analysis of hyperplastic parathyroid glands in multiple endocrine neoplasia type I.
Komatsu M; Nishiyama RH; Bagwell CB
Arch Surg; 1992 Dec; 127(12):1430-4. PubMed ID: 1365689
[TBL] [Abstract][Full Text] [Related]
3. Analysis of proliferative activity of the parathyroid glands using proliferating cell nuclear antigen in patients with hyperparathyroidism.
Yamaguchi S; Yachiku S; Morikawa M
J Clin Endocrinol Metab; 1997 Aug; 82(8):2681-8. PubMed ID: 9253354
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hyperplasia in tertiary hyperparathyroidism: a pathological and immunohistochemical reappraisal.
Harach HR; Jasani B
Histopathology; 1992 Dec; 21(6):513-9. PubMed ID: 1468749
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid glands in uraemic patients with refractory hyperparathyroidism: histopathology and p53 protein expression analysis.
Martin LN; Kayath MJ; Vieira JG; Nosé-Alberti V
Histopathology; 1998 Jul; 33(1):46-51. PubMed ID: 9726048
[TBL] [Abstract][Full Text] [Related]
7. DNA index and ploidy distinguish normal human parathyroids from parathyroid adenomas and primary hyperplastic parathyroids.
Chryssochoos JT; Weber CJ; Cohen C; Moore J; DeRose PB; Hagler M; Bray R; Stempora L; Mainiero M; McGarity WC
Surgery; 1995 Dec; 118(6):1041-9; discussion 1049-50. PubMed ID: 7491521
[TBL] [Abstract][Full Text] [Related]
8. A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients.
Yan J; Jingbo C; Wang D; Xie S; Yuan L; Zhong X; Hao L
Int Urol Nephrol; 2015 Apr; 47(4):701-6. PubMed ID: 25749987
[TBL] [Abstract][Full Text] [Related]
9. Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.
Kifor O; Moore FD; Wang P; Goldstein M; Vassilev P; Kifor I; Hebert SC; Brown EM
J Clin Endocrinol Metab; 1996 Apr; 81(4):1598-606. PubMed ID: 8636374
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hyperplasia in multiple endocrine neoplasia type 1: a pathological and immunohistochemical reappraisal.
Harach HR; Jasani B
Histopathology; 1992 Apr; 20(4):305-13. PubMed ID: 1349556
[TBL] [Abstract][Full Text] [Related]
11. Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression.
Carling T; Rastad J; Ridefelt P; Gobl A; Hellman P; Oberg K; Rask L; Larsson C; Juhlin C; Akerström G
Surgery; 1995 Dec; 118(6):924-30; discussion 930-1. PubMed ID: 7491535
[TBL] [Abstract][Full Text] [Related]
12. Calcitonin immunoreactivity in neoplastic and hyperplastic parathyroid glands: an immunohistochemical study.
Khan A; Tischler AS; Patwardhan NA; DeLellis RA
Endocr Pathol; 2003; 14(3):249-55. PubMed ID: 14586070
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of nodular hyperplastic parathyroid glands in patients with secondary hyperparathyroidism.
Oka T; Yoshioka T; Shrestha GR; Koide T; Sonoda T; Hosokawa S; Onoe K; Sakurai M
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):53-60. PubMed ID: 3131956
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone release in vitro in hyperparathyroidism associated with multiple endocrine neoplasia type 1.
Benson L; Rastad J; Ljunghall S; Rudberg C; Akerström G
Acta Endocrinol (Copenh); 1987 Jan; 114(1):12-7. PubMed ID: 2880443
[TBL] [Abstract][Full Text] [Related]
15. Ultrasonographic evaluation of parathyroid hyperplasia in multiple endocrine neoplasia type 1: Positive correlation between parathyroid volume and circulating parathyroid hormone concentration.
Tamiya H; Miyakawa M; Takeshita A; Miura D; Takeuchi Y
J Bone Miner Metab; 2015 Sep; 33(5):523-9. PubMed ID: 25227285
[TBL] [Abstract][Full Text] [Related]
16. Recurrent hyperparathyroidism due to peroperative seeding of neoplastic or hyperplastic parathyroid tissue. Case report.
Akerström G; Rudberg C; Grimelius L; Rastad J
Acta Chir Scand; 1988 Sep; 154(9):549-52. PubMed ID: 3201872
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the dimension of parathyroid glands estimated by ultrasonography and the hyperplastic pattern in patients with renal hyperparathyroidism.
Matsuoka S; Tominaga Y; Sato T; Uno N; Hiramitu T; Goto N; Nagasaka T; Uchida K
Ther Apher Dial; 2008 Oct; 12(5):391-5. PubMed ID: 18937723
[TBL] [Abstract][Full Text] [Related]
18. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands.
Chen H; Mack E; Starling JR
Ann Surg; 2003 Sep; 238(3):332-7; discussion 337-8. PubMed ID: 14501499
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; A clinico-pathologic challenge. The MD Anderson case series and review of the literature.
Christakis I; Busaidy NL; Cote GJ; Williams MD; Hyde SM; Silva Figueroa AM; Kwatampora LJ; Clarke CN; Qiu W; Lee JE; Perrier ND
Int J Surg; 2016 Jul; 31():10-6. PubMed ID: 27212590
[TBL] [Abstract][Full Text] [Related]
20. Supernumerary parathyroid glands in hyperparathyroidism associated with multiple endocrine neoplasia type 1.
d'Alessandro AF; Montenegro FL; Brandão LG; Lourenço DM; Toledo Sde A; Cordeiro AC
Rev Assoc Med Bras (1992); 2012; 58(3):323-7. PubMed ID: 22735224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
